Chimeric Therapeutics Ltd
ASX:CHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
E
|
Emerson Electric Co
XMUN:EMR
|
US |
|
Ocumetics Technology Corp
F:2QB0
|
CA |
|
A
|
American Health Protection Corp
OTC:EWLL
|
US |
|
W
|
West Pharmaceutical Services Inc
F:WPS
|
US |
|
Pulmonx Corp
NASDAQ:LUNG
|
US |
|
F
|
Fabrinet
F:FAN
|
KY |
|
S
|
Sumitomo Metal Mining Co Ltd
DUS:S19
|
JP |
|
Mersen SA
F:CBE
|
FR |
|
B
|
Brockman Mining Ltd
ASX:BCK
|
HK |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Chimeric Therapeutics Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Chimeric Therapeutics Does
Chimeric Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies.
- Headquarters
- Australia AU
- IPO date
- Jan 18, 2021
